Scott Koenig - 13 Aug 2025 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Director
Signature
/s/ Beth A. Smith, Attorney-in-fact
Issuer symbol
MGNX
Transactions as of
13 Aug 2025
Net transactions value
$0
Form type
4
Filing time
15 Aug 2025, 17:05:12 UTC
Previous filing
19 Feb 2025
Next filing
10 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Koenig Scott Director 9704 MEDICAL CENTER DRIVE, ROCKVILLE /s/ Beth A. Smith, Attorney-in-fact 15 Aug 2025 0001587514

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise $0 +21,165 +2.7% $0.000000 798,580 13 Aug 2025 Direct F1, F2
transaction MGNX Common Stock Options Exercise $0 +31,664 +4% $0.000000 830,244 13 Aug 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Restricted Stock Unit Options Exercise $0 -21,165 -50% $0.000000 21,165 13 Aug 2025 Common Stock 21,165 $0.000000 Direct F1, F2
transaction MGNX Restricted Stock Unit Options Exercise $0 -31,664 -50% $0.000000 31,663 13 Aug 2025 Common Stock 31,664 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to the Separation and Consulting Agreement between the Company and the Reporting Person (the "Separation Agreement"), 50% of the shares with respect to each outstanding and unvested restricted stock unit (RSU) immediately vested. Vested shares will be delivered to the Reporting Person as soon as practicable after the date of vesting.
F2 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.